Accessibility Menu
NIOX Group Plc logo

NIOX Group Plc(LSE) NIOX

Current Price£0.62
Market Cap£260.10MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2014)-78%
5 Year+107%
1 Year-8%
1 Month+7%
NIOX Group Plc last closing stock price
MetricPriceDate
Last closeGBX 62.342026-07-23
NIOX Group Plc stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+5.67%GBX 59.002026-07-16
1 month+7.49%GBX 58.002026-06-23
3 month-5.54%GBX 66.002026-04-24
Year to date-6.11%GBX 66.402025-12-31
1 year-7.5%GBX 67.402025-07-23
3 year-7.91%GBX 67.702023-07-24
5 year+107.13%GBX 30.102021-07-23
Since inception-78.08%GBX 2.822014-03-13

NIOX Group Plc Financials at a Glance

Market Cap

£260.10MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

£90.50M

Net Income (TTM)

£10.70M

EPS (TTM)

£0.02

P/E Ratio

36.35

Dividend

£0.02

Beta (Volatility)

0.01 (Low)

Price

£0.62

Volume

344,371

Open

£0.63

Previous Close

£0.62

Daily Range

£0.62 - £0.64

52-Week Range

£0.54 - £0.78

Estimated Earnings Date

Sep 10, 2026

NIOX News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About NIOX Group Plc

NIOX Group Plc is a global leader in the development and distribution of medical devices that measure fractional exhaled nitric oxide (FeNO). The company specializes in innovative diagnostic tools, particularly the NIOX VERO system, which is designed for immediate, non-invasive patient use.

Products and Services
  • NIOX VERO system for measuring FeNO levels
  • Portable and user-friendly diagnostic devices
  • Comprehensive suite of disposable items for patient testing
Growth Outlook
  • Revenue increased to £25.2 million in Q2 2025, up from £23.5 million in Q1 2025
  • Net income reached £5.9 million in Q2 2025, showcasing strong profitability
  • Operating cash flow of £8.8 million in Q4 2025 indicates robust cash generation
Financial Highlights
  • Trailing twelve-month revenue of £90 million, reflecting consistent growth
  • Net profit margin of 14.37% demonstrates effective cost management
  • Current ratio of 3.81 indicates strong liquidity position
NIOX Group Plc has established itself as a key player in the medical devices sector, focusing on innovative solutions for respiratory health. The NIOX VERO system stands out for its portability and ease of use, making it a valuable tool for healthcare providers. Recent financial performance highlights a positive trajectory, with significant revenue growth and strong profitability metrics. The company's ability to generate substantial operating cash flow further underscores its financial health. With a solid market position and a commitment to innovation, NIOX Group Plc presents an intriguing opportunity for potential investors interested in the healthcare sector.
AI Generated • Jul 20, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

97

CEO

Jonathan Emms

Website

www.circassia.co.uk

Headquarters

Oxford, OX OX4 4GB, GB

NIOX Financials

Key Financial Metrics (TTM)

Gross Margin

60.78%

Operating Margin

21.97%

Net Income Margin

14.37%

Return on Equity

10.14%

Return on Capital

14.32%

Return on Assets

9.19%

Earnings Yield

2.75%

Dividend Yield

2.51%

Payout Ratio

71.43%

Stock Overview

Market Cap

£260.10MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

420.87M

Volume

344.37K

Avg. Volume

874.15K

Financials (TTM)

Gross Profit

£57.70M

Operating Income

£18.40M

EBITDA

£27.00M

Operating Cash Flow

£33.40M

Capital Expenditure

-£200.00K

Free Cash Flow

£33.20M

Cash & ST Invst.

£19.90M

Total Debt

£1.00M

NIOX Group Plc Performance Analysis

NIOX Group Plc annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31GBP 31,300,00012.2%
20232023-12-31GBP 36,800,00017.6%
20242024-12-31GBP 41,800,00013.6%
20252025-12-31GBP 48,700,00016.5%
NIOX Group Plc sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-06-2916.7%
Q42024-12-31-1.0%
Q22025-06-3021.2%
Q42025-12-31-6.7%
NIOX Group Plc annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31GBP 0.04337.3%
20232023-12-31GBP 0.02-34.4%
20242024-12-31GBP 0.01-65.1%
20252025-12-31GBP 0.0297.6%
NIOX Group Plc sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-06-29-34.0%
Q42024-12-31-118.6%
Q22025-06-30872.2%
Q42025-12-31-81.3%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

£23.50M

+30.6%

Gross Profit

£14.00M

+9.4%

Gross Margin

59.57%

N/A

Market Cap

£260.10MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

£2.68M

N/A

Employees

97

N/A

Net Income

£1.10M

-83.3%

EBITDA

£6.90M

+102.9%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Total Cash

£19.90M

+0.0%

Total Debt

£1.00M

-9.1%

Accounts Receivable

£6.00M

-31.8%

Inventory

£5.00M

+4.2%

Long Term Debt

£500.00K

+0.0%

Short Term Debt

£500.00K

-58.3%

Return on Assets

9.19%

N/A

Return on Invested Capital

15.71%

N/A

Free Cash Flow

£8.60M

+30.3%

Operating Cash Flow

£8.80M

+33.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
BXP.LBeximco Pharmaceuticals Limited
£0.54+1.81%
ANCR.LAnimalcare Group plc
£3.33-0.05%
PRTC.LPureTech Health plc
£1.21-2.58%
AGY.LAllergy Therapeutics plc
£0.06+9.09%

Trending Stocks

Symbol / CompanyPricePrice Chg
NOKNokia
$10.28-0.03%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$10.96-0.02%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$40.94+0.02%
TQQQProShares Trust - ProShares UltraPro Qqq
$70.28-0.02%

Questions About NIOX

What is the current price of NIOX Group Plc?

NIOX Group Plc is trading at £0.62 per share.

What is the 52-week range for NIOX Group Plc?

Over the past 52 weeks, NIOX Group Plc has traded between £0.54 and £0.78.

How much debt does NIOX Group Plc have?

As of the most recent reporting period, NIOX Group Plc reported total debt of £1.00M.

How much cash does NIOX Group Plc have on hand?

NIOX Group Plc reported £19.90M in cash and cash equivalents in its most recent financial results.

What is NIOX Group Plc’s dividend yield?

NIOX Group Plc currently has a dividend yield of 2.51%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services